Business Wire

FOURKITES

23.9.2022 09:01:38 CEST | Business Wire | Press release

Share
FourKites’ Latest European Premier Carrier List Reflects ROI of High-quality Real-Time Supply Chain Visibility Data

Leading real-time supply chain visibility provider FourKites today published its global Premier Carrier List (PCL), which recognises the rapidly growing community of brokers, carriers and 3PLs who are achieving the highest standards of visibility-related operational excellence across all modes of transport.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220923005062/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites’ Latest European Premier Carrier List Reflects ROI of High-quality Real-Time Supply Chain Visibility Data (Graphic: Business Wire)

To qualify for the PCL, carriers must demonstrate an ability to provide high-quality, consistent and accurate data on the vast majority of their shipments, thereby enabling their shipper customers and other ecosystem partners to streamline operations, increase the speed of shipping dock turn times, reduce inventory levels and optimise labour costs.

In the first half of 2022, 685 carriers were named to the PCL, which included an 8% increase for carriers based in Europe. These Premier Carriers demonstrated a significantly higher tracking percentage, on average, versus non-PCL carriers. Over the last six months, carriers who qualified for the Premier Carrier List tracked an average of 92.6% of their over-the-road shipments with real-time visibility, while non-PCL carriers tracked only 74.3% of their shipments.

“We partnered with FourKites because we wanted to grow our business,” says Vladas Stončius, CCO, Vlantana. “Increasingly, suppliers expect carriers to provide real-time data on all shipments. Thanks to FourKites, we’re able to do that efficiently and consistently, which has enabled us to win bigger customers and boost our margins.”

Notably, Premier Carriers witnessed higher growth rates than their non-PCL counterparts. In Europe, from H2 2021 to H1 2022, Premier Carriers experienced shipment volume growth of 9%, compared to non-PCL carriers in the region, who saw shipment volume contract 2%.

“Qualifying for FourKites’ Premier Carrier List is an increasingly important distinction for carriers, brokers and 3PLs who need to stand out in an increasingly competitive and volatile market,” said Jason Eversole, Vice President, Carrier Operations & Strategy, FourKites. “We’re pleased to see continued growth in the total number of Premier Carriers, and equally pleased to see the clear business benefits they are experiencing as a result of their visibility-related excellence.”

The Premier Carrier List is available here, where users can access and search the list according to carrier capabilities, transportation modes, geographies serviced and other relevant criteria.

Premier Carriers speak to program benefits:

"Transervice is honored to be recognised as a FourKites Premier Carrier. FourKites has enabled Transervice, and our clients, with unparalleled visibility into our logistics operations. This capability ensures complete transparency throughout the supply chain and promotes efficient resource utilisation. We are proud to partner with FourKites, and we look forward to their continued growth and innovation."

- Tom Poduch, Senior Director, Solutions, at Transervice

“Van den Bosch is always on the lookout for new opportunities to make its supply chain more efficient and sustainable. Fueled by data, insights and knowledge, innovation and digitalisation are key drivers. The qualification for Premier Carrier is a nice recognition and confirmation of our position as the supply changer in bulk.”

- Marrit Hopmans, Data & Applications Manager, Van den Bosch

“As a former employee of FourKites, I’ve experienced firsthand how imperative their technology is to the entire industry. TransLoop is extremely proud to be recognised as a FourKites Premier Carrier. We will continue to do whatever our shipper and carrier partners need us to do for TransLoop to be the most transparent and reliable broker partner in the industry.”

- Nick Reasoner, CEO, TransLoop

About FourKites

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.8 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit www.fourkites.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220923005062/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye